The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

Vanda Pharmaceuticals (VNDA) stock saw a 9% premarket drop after FDA rejection of its therapy for gastroparesis, citing need ...

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster ... Other pharmaceutical companies are also entering the race to develop oral GLP-1 treatments. Eli Lilly is testing an ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 584.52% and ...

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...